TAVR positioning and its effect on valve and heart blood flow
Part of Heart & circulation clinical trials.
This study looks at how the placement of a new aortic valve (TAVR) affects blood flow through the valve and into the heart arteries. It may help doctors understand best practices for people who already had a TAVR procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a TAVR procedure done through an artery in your leg (not your chest or arm).
- This is your first valve replacement in that position (no prior valve-in-valve or other bioprosthetic valve there).
- You do not have a permanent pacemaker, ICD, or CRT device.
- You do not have liver cirrhosis or any esophageal problems like varices.
- You do not have low platelets or a bleeding disorder.
- You are able to give consent and follow study procedures, including follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study tests whether a more precise way of aligning the replacement valve during a minimally invasive aortic valve procedure improves outcomes. It may help people with severe aortic stenosis get a longer-lasting, better-functioning valve.
This study tests different ways to check for blocked heart arteries in patients getting a new aortic valve through a tube in the leg. It aims to find the best approach to guide treatment.
This study tests a new replacement valve for the aortic heart valve, delivered through a catheter (a thin tube) — a procedure called TAVR. It is for people who have severe aortic stenosis and are not good candidates for open-heart surgery.
This trial studies people with severe aortic valve disease who will receive a catheter-based valve replacement (TAVR). It aims to check how well this approach works for fixing a narrowed or leaky aortic valve, and to monitor outcomes afterward.
This study checks whether a quick bedside blood test helps guide care during a minimally invasive TAVI procedure (a new valve put in without open-heart surgery). It may improve safety and outcomes by helping the team manage bleeding-related decisions in real time.
Hear when a new Transcatheter Aortic Valve Replacement trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.